Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
01/2004
01/01/2004US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound
01/01/2004US20040002510 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
01/01/2004US20040002491 Melatonergic receptors
01/01/2004US20040002490 Melatonergic receptors
01/01/2004US20040002488 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
01/01/2004US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents
12/2003
12/31/2003WO2004000842A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
12/31/2003WO2004000816A1 Androgen receptor agonist
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003CN1463975A Novel harringtonlne derivative, method for making same and its pharmaceutical composition and use thereof
12/31/2003CN1132837C 螺呋喃并吡啶芳烷基胺、其制法和中间体及其药物组合物和制药用途 Spiro furopyridine arylalkylamines, their preparation and intermediates and pharmaceutical compositions thereof and pharmaceutical use
12/31/2003CN1132836C 各种片螺素化合物和类似物的合成及中间体 And various synthetic intermediates lamellarin compounds and the like
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670488 Substituted phenylketoenols
12/30/2003US6670367 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists
12/30/2003US6670356 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
12/30/2003US6670307 1,3-oxazoline and 1,3-thiazoline derivatives, their preparation, and their use as pesticides
12/25/2003WO2003106424A1 Process for the manufacture of quinoline derivatives
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236295 Tricylic indole compounds having affinity for serotonin receptor
12/25/2003US20030236271 Antitumor agents; enzyme inhibitors
12/25/2003US20030236262 Dietetics; antidiabetic agents; sexual disorders
12/25/2003US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents
12/25/2003US20030236259 Novel aryl- and heteroarylpiperazines
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030236229 For stimulating the immune system, treating proliferative disorders, or microbial infections
12/25/2003US20030236220 Mucin synthesis inhibitors
12/24/2003WO2003106653A2 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof
12/24/2003WO2003106457A1 Spiroindolinepiperidine derivatives
12/24/2003WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003WO2003106450A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
12/24/2003WO2003105724A2 Novel maxi-k channel blockers, methods of use and process for making the same
12/24/2003CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine
12/24/2003CN1131854C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
12/24/2003CA2488752A1 Novel maxi-k channel blockers, methods of use and process for making the same
12/24/2003CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/23/2003US6667315 Pyridoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates)
12/23/2003CA2267800C Tricyclic compounds having activity as ras-fpt inhibitors
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/23/2003CA2116387C Oxazolidinedione derivatives, their production and use
12/23/2003CA2059063C Novel antiviral compounds
12/18/2003WO2003104238A1 Novel compound having antitumor activity and process for producing the same
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104229A1 Novel fused imidazole derivative
12/18/2003WO2003082192A3 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003WO2003013536A3 Methods for treatment of cancer using irinotecan based on ugt1a1
12/18/2003US20030232993 Process for preparing scopine esters
12/18/2003US20030232874 Methods and compositions for the treatment of chronic lymphocytic leukemia
12/18/2003US20030232872 Selective serotonin receptor antagonists and therapeutic applications thereof
12/18/2003US20030232865 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases
12/17/2003EP1370562A1 Thieno[2,3-d]pyrimidindione derivatives as matrix metalloproteinase inhibitors
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370529A1 Substituted dimethyl- 1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics
12/17/2003EP0937075B1 New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
12/17/2003CN1462435A Optical data carrier containing phthalocyanine colouring agent as light absorbing compound in information layer
12/17/2003CN1462358A Optical data storage device containing Co-Phthalocyanin complex in optically writable information layer
12/17/2003CN1462273A Bicyclic heteroaromatic compounds
12/17/2003CN1461585A Prodn. of 10-hydroxy camptothecine, and method for processing raw material of camptothecine
12/17/2003CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists
12/17/2003CN1131219C Process for preparation of phenylimidazolidine derives
12/17/2003CN1131217C Phenylazole compound, process for producing the same and drugs for hyperlipemia
12/17/2003CN1131216C Condensed 1,2-indene dihydride and its salt for medicine its preparation method and application
12/17/2003CN1131215C Cyclic and heterocyclic n-substituted 'alpha'-iminoh-ydroxamic acid and carboxylic acids
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/11/2003WO2003101998A1 Nitrogen-based homo-camptothecin derivatives
12/11/2003WO2003101996A2 Esters in position 20 of camptothecins
12/11/2003WO2003101995A2 Camptothecins with a modified lactone ring
12/11/2003WO2003101994A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
12/11/2003WO2003101985A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003WO2003101916A1 Method of substituent introduction through halogen-metal exchange reaction
12/11/2003WO2003101406A1 Homo-camptothecin derivatives
12/11/2003WO2003101379A2 Pyranoindazoles and their use for the treatment of glaucoma
12/11/2003WO2003051289A3 Solubilized topoisomerase poison agents
12/11/2003WO2003043584A3 Engineered liposomal particles containing core-loaded pro-drugs for the controlled release of camptothecins
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2002083067A3 Prodrugs via acylation with cinnamate
12/11/2003US20030229136 Anticancer agents; antiproliferative agents
12/11/2003US20030229115 Organ rejection disease; autoimmune disease; immunosuppressants
12/11/2003US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents
12/11/2003US20030229084 Osteoporosis; antiarthritic agents
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229071 Solvent extraction, separation, crystallization
12/11/2003US20030229068 Controlling apoptosis, cell proliferation; strokes; anticancer agents; central nervous system disorders
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030228984 Novel substituted phenylketoenols
12/11/2003CA2706635A1 Camptothecins with a modified lactone ring
12/11/2003CA2486832A1 Pyranoindazoles and their use for the treatment of glaucoma
12/11/2003CA2486530A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/10/2003EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/10/2003EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
12/10/2003EP1177191B1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
12/10/2003EP0970086B1 Spiro compounds and the use thereof
12/10/2003EP0853615B1 Piperidine compounds as calcium channel blockers
12/10/2003EP0714396B1 Vasocontrictive dihydrobenzopyran derivatives
12/10/2003CN1130366C Substituted phenylketoenols and preparing method, midbody and their use as pestcides and herbicides
12/10/2003CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use
12/10/2003CN1130359C Substituted benzimidazole, its preparation and use as means against parastic protozoa
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 298